Drugs acting on renin angiotensin system and use in ill patients with COVID-19

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 8, e21, 10.1016/S2213-2600(20)30116-8 Donoghue, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9, Circ Res, 87, E1, 10.1161/01.RES.87.5.e1 Tipnis, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J Biol Chem, 275, 33238, 10.1074/jbc.M002615200 Vaduganathan, 2020, Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19, N Engl J Med, 382, 1653, 10.1056/NEJMsr2005760 Choi, 2020, Angiotensin-[1–7] attenuates kidney injury in experimental Alport syndrome, Sci Rep, 10, 4225, 10.1038/s41598-020-61250-5 Karnik, 2015, Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli [corrected], Pharmacol Rev, 67, 754, 10.1124/pr.114.010454 Santos, 2018, The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7), Physiol Rev, 98, 505, 10.1152/physrev.00023.2016 Deshotels, 2014, Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism, Hypertension, 64, 1368, 10.1161/HYPERTENSIONAHA.114.03743 Kostenis, 2005, G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor, Circulation, 111, 1806, 10.1161/01.CIR.0000160867.23556.7D Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med, 11, 875, 10.1038/nm1267 Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786 Ferrario, 2005, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, 111, 2605, 10.1161/CIRCULATIONAHA.104.510461 Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712 Xu, 2020, High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int J Oral Sci, 12, 8, 10.1038/s41368-020-0074-x Kuhn, 2004, Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus, Cell Mol Life Sci, 61, 2738, 10.1007/s00018-004-4242-5 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 10.1016/j.cell.2020.02.052 Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5 Chen, 2020, Structure analysis of the receptor binding of 2019-nCoV, Biochem Biophys Res Commun Shang, 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 10.1016/j.cell.2020.02.058 Hofmann, 2004, Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor, Biochem Biophys Res Commun, 319, 1216, 10.1016/j.bbrc.2004.05.114 Kuba, 2006, Angiotensin-converting enzyme 2 in lung diseases, Curr Opin Pharmacol, 6, 271, 10.1016/j.coph.2006.03.001 Chen, 2020, Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19), medRxiv Gurwitz, 2020, Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics, Drug Dev Res, 10.1002/ddr.21656 Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8 Zhang, 2020, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Intensive Care Med, 46, 586, 10.1007/s00134-020-05985-9 Puertas, 2020, ACE2 Activators for the treatment of Covid 19 patients, J Med Virol Li, 2020, Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor, Pharmacol Res, 157, 104833, 10.1016/j.phrs.2020.104833 Monteil, 2020, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 10.1016/j.cell.2020.04.004 Khan, 2017, A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome, Crit Care Lond Engl, 21, 234, 10.1186/s13054-017-1823-x Warner, 2004, Angiotensin-converting enzyme-2: a molecular and cellular perspective, Cell Mol Life Sci, 61, 2704, 10.1007/s00018-004-4240-7 Rice, 2004, Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism, Biochem J, 383, 45, 10.1042/BJ20040634 Ishiyama, 2004, Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors, Hypertension, 43, 970, 10.1161/01.HYP.0000124667.34652.1a Ocaranza, 2006, Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat, Hypertension, 48, 572, 10.1161/01.HYP.0000237862.94083.45 Ramchand, 2018, Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease, PloS One, 13, e0198144, 10.1371/journal.pone.0198144 Walters, 2017, Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling, Europace, 19, 1280 Campbell, 2004, Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation, J Hypertens, 22, 1971, 10.1097/00004872-200410000-00020 Luque, 1996, Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension, J Hypertens, 14, 799, 10.1097/00004872-199606000-00017 Danser, 2020, Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers, Hypertension, 75, 1382, 10.1161/HYPERTENSIONAHA.120.15082 Mourad, 2020, Interaction between RAAS inhibitors and ACE2 in the context of COVID-19, Nat Rev Cardiol, 17, 313, 10.1038/s41569-020-0368-x Keidar, 2005, Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients, Circ Res, 97, 946, 10.1161/01.RES.0000187500.24964.7A Zhong, 2011, Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression, Regul Pept, 166, 90, 10.1016/j.regpep.2010.09.005 Kreutz, 2020, Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19, Cardiovasc Res, 10.1093/cvr/cvaa097 Nicin, 2020, Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts, Eur Heart J, 41, 1804, 10.1093/eurheartj/ehaa311 Sriram, 2020, Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence, Clin Pharmacol Ther, 10.1002/cpt.1863 Goulter, 2004, ACE2 gene expression is up-regulated in the human failing heart, BMC Med, 2, 19, 10.1186/1741-7015-2-19 Anguiano, 2017, Circulating ACE2 in cardiovascular and kidney diseases, Curr Med Chem, 24, 3231, 10.2174/0929867324666170414162841 Bhatraju, 2020, Covid-19 in critically ill patients in the Seattle region — Case series, N Engl J Med, 10.1056/NEJMoa2004500 Aronson, 2020, Drugs and the renin-angiotensin system in covid-19, BMJ, 369, m1313, 10.1136/bmj.m1313 Sommerstein, 2020, Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?, J Am Heart Assoc, 9, e016509, 10.1161/JAHA.120.016509 Guo, 2020, J Am Heart Assoc, 9, e016219, 10.1161/JAHA.120.016219 Zhang, 2020, Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19, Circ Res Meng, 2020, Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension, Emerg Microbes Infect, 9, 757, 10.1080/22221751.2020.1746200 Société française d’hypertension artérielle, 2020 2020 Kuster, 2020, SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?, Eur Heart J, 41, 1801, 10.1093/eurheartj/ehaa235 Bai, 2013, Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat, Regul Pept, 184, 54, 10.1016/j.regpep.2013.03.005 Iizuka, 2009, Angiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells, J Renin Angiotensin Aldosterone Syst, 10, 210, 10.1177/1470320309343710 Takai, 2013, Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats, Hypertens Res, 36, 342, 10.1038/hr.2012.187 Zhao, 2019, AHU377+valsartan (LCZ696) modulates renin-angiotensin system (RAS) in the cardiac of female spontaneously hypertensive rats compared with valsartan, J Cardiovasc Pharmacol Ther, 24, 450, 10.1177/1074248419838503 Jessup, 2008, Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats, J Am Soc Hypertens, 2, 106, 10.1016/j.jash.2007.10.005 Dong, 2019, Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes, Int Urol Nephrol, 51, 755, 10.1007/s11255-019-02074-9 Yamamuro, 2008, Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes, Circ J, 72, 1346, 10.1253/circj.72.1346 Igase, 2005, Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol, 289, H1013, 10.1152/ajpheart.00068.2005